Pubblicazioni

RNA editing signature during myeloid leukemia cell differentiation

2017 - LEUKEMIA

ROSSETTI, CLAUDIA; Picardi, E; YE, MANUELA; CAMILLI, GIORGIO; DâErchia, A. M; Cucina, L; Locatelli, F; Fianchi, L; Teofili, L; Pesole, G; Gallo, A; SORRENTINO, Rosa

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia

2017 - LEUKEMIA

Bernson, E.; Hallner, A.; Sander, F. E.; Wilsson, O.; Werlenius, O.; RydstrÃ¶m, A.; Kiffin, R.; Brune, M.; FoÃ , R.; Aurelius, J.; Martner, A.; Hellstrand, K.; ThorÃ©n, F. B.

Characterization of children with flt3-itd acute myeloid leukemia. a report from the aieop aml-2002 study group

2017 - LEUKEMIA

Manara, E.; Basso, G.; Zampini, M.; Buldini, B.; Tregnago, C.; Rondelli, R.; Masetti, R.; Bisio, V.; Frison, M.; Polato, K.; Cazzaniga, G.; Menna, G.; Fagioli, F.; Merli, P.; Biondi, A.; Pession, A.; Locatelli, F.; Pigazzi, M.

NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group

2017 - LEUKEMIA

Bisio, V.; Zampini, M.; Tregnago, C.; Manara, E.; Salsi, V.; Di Meglio, A.; Masetti, R.; Togni, M.; Di Giacomo, D.; Minuzzo, S.; Leszl, A.; Zappavigna, V.; Rondelli, R.; Mecucci, C.; Pession, A.; Locatelli, F.; Basso, G.; Pigazzi, M.

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol

2017 - LEUKEMIA

Driessen, E. M. C.; de Lorenzo, P.; Campbell, M.; Felice, M.; Ferster, A.; Hann, I.; Vora, A.; Hovi, L.; Escherich, G.; Li, C. K.; Mann, G.; Leblanc, T.; Locatelli, F.; Biondi, A.; Rubnitz, J.; Schrappe, M.; Silverman, L.; Stary, J.; Suppiah, R.; Szczepanski, T.; Valsecchi, M.; Pieters, R.

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomibâdexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

2017 - LEUKEMIA

Ludwig, H; Weisel, K.; Petrucci, M. T.; Leleu, X.; Cafro, A. M.; Garderet, L.; Leitgeb, C.; Foa, Roberto; Greil, R.; Yakoub Agha, I.; Zboralski, D.; VaulÃ©on, S.; DÃ¼mmler, T.; Beyer, D.; Kruschinski, A.; Riecke, K.; Baumann, M.; Engelhardt, M.

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with <= 30% blasts

2017 - LEUKEMIA

Garcia-Manero, G; Sekeres, Ma; Egyed, M; Breccia, M; Graux, C; Cavenagh, Jd; Salman, H; Illes, A; Fenaux, P; Deangelo, Dj; Stauder, R; Yee, K; Zhu, N; Lee, Jh; Valcarcel, D; Macwhannell, A; Borbenyi, Z; Gazi, L; Acharyya, S; Ide, S; Marker, M; Ottmann, Og

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

2017 - LEUKEMIA

Natoni, A; Smith, T A G; Keane, N; Mcellistrim, C; Connolly, C; Jha, A; Andrulis, M; Ellert, E; Raab, M S; Glavey, S V; Kirkham-McCarthy, L; Kumar, S K; Locatelli-Hoops, S C; Oliva, I; Fogler, W E; Magnani, J L; O'Dwyer, M E

MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs

2017 - LEUKEMIA

Pyzer, A R; Stroopinsky, D; Rosenblatt, J; Anastasiadou, E; Rajabi, H; Washington, A; Tagde, A; Chu, J-H; Coll, M; Jiao, A L; Tsai, L T; Tenen, D E; Cole, L; Palmer, K; Ephraim, A; Leaf, R K; Nahas, M; Apel, A; Bar-Natan, M; Jain, S; Mcmasters, M; Mendez, L; Arnason, J; Raby, B A; Slack, F; Kufe, D; Avigan, D